Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs CarMax, Inc (KMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs CarMax, Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while CarMax, Inc trades at $51.99 (market cap $7.07B). The key difference: CarMax, Inc is the larger of the two by market cap, and CarMax, Inc is more actively traded (2,330,911.51 versus 2,781,171). Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and CarMax, Inc for 49 Days on average.
| INDV | KMX | |
|---|---|---|
Market Cap | $4.03B | $7.07B |
Volume | 2,781,171 | 2,330,911.51 |
Sector | Health | Consumer Cyclical |
52-Week High | $41.83 | $64.22 |
52-Week Low | $24.09 | $30.88 |
Typical Hold Time | 0 Days | 49 Days |
Enterprise Value | $4.32B | $24.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CarMax (KMX) trades at $50.81, up 0.24% with bearish technical signals despite recent earnings beats. The company reported strong Q2 2027 results with EPS of $1.16 beating estimates by 58%, driven by 19.5% revenue growth to $7.9 billion. However, net income margin remains thin at 1.06% and cash flow trends show recent weakness with negative net cash flow of $290 million in 2025.
While CarMax's turnaround strategy shows early success with improved sales volume, high debt levels and compressed margins present significant risks. The consensus price target of $61 offers 20% upside potential, but technical indicators suggest near-term pressure. The stock faces headwinds from competitive pricing pressures and macroeconomic sensitivity to consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Read more on KMX →
